Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024
19 avr. 2024 16h05 HE
|
Olink Proteomics AB
UPPSALA, Sweden, April 19, 2024 (GLOBE NEWSWIRE) -- At the Annual General Meeting (the “AGM”) of Olink Holding AB (publ), reg. no 559189-7755, (the “Company”), on 19 April 2024 the AGM adopted,...
Olink® Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of Disease
02 avr. 2024 08h00 HE
|
Olink Proteomics AB
Olink delivers new open access data library consisting of over 300,000 protein-disease risk associations across 106 human diseases.
Olink publishes 2023 annual report
25 mars 2024 08h00 HE
|
Olink Proteomics AB
UPPSALA, Sweden, March 25, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that the Annual Report for 2023 is now available on the Company’s website at...
Olink reports fourth quarter and full year 2023 financial results
25 mars 2024 08h00 HE
|
Olink Proteomics AB
UPPSALA, Sweden, March 25, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the fourth quarter ended December 31, 2023. ...
Notice to attend the Annual General Meeting of Olink Holding AB (publ)
15 mars 2024 08h00 HE
|
Olink Proteomics AB
UPPSALA, Sweden, March 15, 2024 (GLOBE NEWSWIRE) -- The shareholders of Olink Holding AB (publ) (the “Company” or “Olink”), reg. no. 559189-7755, are hereby given notice to attend the Annual General...
Olink announces change of date for Annual General Meeting
08 mars 2024 08h00 HE
|
Olink Proteomics AB
UPPSALA, Sweden, March 08, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that Olink’s 2024 Annual General Meeting (“AGM”) will be held in Uppsala, Sweden...
Olink reports third quarter 2023 financial results
15 nov. 2023 07h00 HE
|
Olink Proteomics AB
UPPSALA, Sweden, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the third quarter ended September 30, 2023. ...
Novogene Asia Pacific Middle East and Africa adopts Olink® Explore HT technology to accelerate multi-omics research with next generation proteomics
05 nov. 2023 20h00 HE
|
Olink Proteomics AB
Novogene AMEA to begin offering Olink Explore HT high-throughput proteomics services to unravel the connections between genes, proteins, and diseases.
Landmark studies utilizing Olink® Explore technology signal a new era for population-scale proteogenomics
05 oct. 2023 16h25 HE
|
Olink Proteomics AB
Three landmark studies published in Nature demonstrate the power of Olink technology for understanding human biology.
Announcing the Olink® Target 48 Mouse Cytokine Panel – the next generation in immunoassays designed to accelerate translational research.
19 sept. 2023 03h00 HE
|
Olink Proteomics AB
Uppsala, Sweden, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Announcing the Olink® Target 48 Mouse Cytokine Panel – the next generation in immunoassays designed to accelerate translational research. ...